licensing agreements

R&D

Closed & Collaborative H2 2025: Mergers, acquisitions, partn...

The second half of 2025 showed pharma and healthcare leaning into partnerships that de‑risk innovation and compress time to market.

News

Gilead strikes deal to expand HIV drug access in 120 countri...

Gilead Sciences has taken a major step towards increasing global access to HIV prevention with the signing of royalty-free

Market Access

SteinCares and Sandoz: Bringing high-quality healthcare prod...

Recently, pharmaphorum spoke with Sebastian Katz, chief strategy officer of specialty healthcare company Stein Holding Group (SteinCares), to discuss the announcement of its licensing agree

Events

Partner Content

EU Pharmaceutical Law Forum

DIG DEEPER INTO CUTTING EDGE TOPICS

Closed & Collaborative H2 2025: Mergers, acquisitions, partn...

Gilead strikes deal to expand HIV drug access in 120 countri...

SteinCares and Sandoz: Bringing high-quality healthcare prod...

EU Pharmaceutical Law Forum

ASCO 2026: Chinese firms take a front seat in oncology, with...

Discover a new era of healthcare panel engagement: Grounded ...

licensing agreements

Editor's Picks